Leasehold Improvements and Equipment |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Property, Plant and Equipment [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Leasehold Improvements and Equipment |
Note 6 – Leasehold Improvements and Equipment
Leasehold improvements and equipment, summarized by major category, consist of the following as of September 30, 2025 and December 31, 2024:
Depreciation and amortization expense for the three and nine months ended September 30, 2025 was $2 and $29, respectively. Depreciation and amortization expense for the three and nine months ended September 30, 2024 was $90 and $275, respectively.
Assets held for sale, net
On April 19, 2025, the Company initiated a process to sell certain unused laboratory equipment that was previously impaired and carried a net book value of $280. During the nine months ended September 30, 2025, the Company sold $210 of the equipment, generating proceeds of $320 and a gain of $110. As of September 30, 2025, the remaining $70 of equipment is classified as held for sale on the Company’s balance sheet. We expect the remaining equipment to be sold prior to December 31, 2025.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||